The subject is engaged with the registration of pharmaceutical and in-licensed products, investment in strategic alliances, and the manufacturing, import, export, marketing, purchasing, selling, formulation, processing, extraction, distribution, and packaging of pharmaceutical, medicinal, and veterinary compounds, preparations, and drugs intended for use in the diagnosis, treatment, mitigation, or prevention of diseases or disorders in humans and animals.

Headquarters
Unit 26-C 26Th Floor, Rufino Pacific Tower
City Of Makati; Fourth District, National Capital Region (Ncr);

Contact Details: Purchase the Lupin Philippines, Inc. report to view the information.

Basic Information

Financial Auditors:

Purchase the Lupin Philippines, Inc. report to view the information.

Incorporation Date:

December 20, 2010

Ownership Details

Purchase this report to view the information.

Subsidiaries

Generic Health Pty Ltd (Australia)

100%

Generic Health Sdn. Bhd. (Malaysia)

100%

Lupin Inc. (United States)

100%

Company Performance

Financial values in the chart are available after Lupin Philippines, Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.

Net sales revenue

185.35%▲

Total operating revenue

185.35%▲

Net Profit (Loss) for the Period

N/A

Total Assets

126.89%▲

Total Equity

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

878.75%▲

Lupin Philippines, Inc. (Philippines)